U.S. halts usage of Johnson & Johnson coronavirus vaccine over rare blood clots
U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. Johnson & Johnson said it would delay rollout of the… Read More U.S. halts usage of Johnson & Johnson coronavirus vaccine over rare blood clots